ETNB
Price
$9.09
Change
-$0.34 (-3.61%)
Updated
Aug 25, 04:59 PM (EDT)
Capitalization
1.4B
73 days until earnings call
KALV
Price
$13.01
Change
-$0.40 (-2.98%)
Updated
Aug 25, 04:59 PM (EDT)
Capitalization
675.06M
10 days until earnings call
Interact to see
Advertisement

ETNB vs KALV

Header iconETNB vs KALV Comparison
Open Charts ETNB vs KALVBanner chart's image
89bio
Price$9.09
Change-$0.34 (-3.61%)
Volume$40.95K
Capitalization1.4B
KalVista Pharmaceuticals
Price$13.01
Change-$0.40 (-2.98%)
Volume$12.17K
Capitalization675.06M
ETNB vs KALV Comparison Chart in %
Loading...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KALV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ETNB vs. KALV commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETNB is a Hold and KALV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (ETNB: $9.43 vs. KALV: $13.41)
Brand notoriety: ETNB and KALV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETNB: 87% vs. KALV: 45%
Market capitalization -- ETNB: $1.4B vs. KALV: $675.06M
ETNB [@Biotechnology] is valued at $1.4B. KALV’s [@Biotechnology] market capitalization is $675.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETNB’s FA Score shows that 1 FA rating(s) are green whileKALV’s FA Score has 0 green FA rating(s).

  • ETNB’s FA Score: 1 green, 4 red.
  • KALV’s FA Score: 0 green, 5 red.
According to our system of comparison, ETNB is a better buy in the long-term than KALV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETNB’s TA Score shows that 6 TA indicator(s) are bullish while KALV’s TA Score has 6 bullish TA indicator(s).

  • ETNB’s TA Score: 6 bullish, 4 bearish.
  • KALV’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ETNB and KALV are a good buy in the short-term.

Price Growth

ETNB (@Biotechnology) experienced а +2.17% price change this week, while KALV (@Biotechnology) price change was +4.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was +18.77%, and the average quarterly price growth was +29.32%.

Reported Earning Dates

ETNB is expected to report earnings on Nov 06, 2025.

KALV is expected to report earnings on Sep 04, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETNB($1.4B) has a higher market cap than KALV($675M). KALV YTD gains are higher at: 58.323 vs. ETNB (20.588). KALV has higher annual earnings (EBITDA): -173.33M vs. ETNB (-442.86M). ETNB has more cash in the bank: 561M vs. KALV (221M). KALV has less debt than ETNB: KALV (6.31M) vs ETNB (37.6M). ETNB (0) and KALV (0) have equivalent revenues.
ETNBKALVETNB / KALV
Capitalization1.4B675M207%
EBITDA-442.86M-173.33M256%
Gain YTD20.58858.32335%
P/E RatioN/AN/A-
Revenue00-
Total Cash561M221M254%
Total Debt37.6M6.31M596%
FUNDAMENTALS RATINGS
KALV: Fundamental Ratings
KALV
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ETNBKALV
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 15 days ago
86%
Bearish Trend 18 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KALV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DAGVX49.240.86
+1.78%
BNY Mellon Dynamic Value Fund A
NMGAX18.800.27
+1.46%
Neuberger Berman Mid Cap Growth A
IMIDX22.730.32
+1.43%
Congress Mid Cap Growth Institutional
SGAPX24.260.30
+1.25%
Virtus SGA Global Growth I
SAOCX36.190.17
+0.47%
NAA Opportunity C

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
+2.61%
AKRO - ETNB
60%
Loosely correlated
+1.95%
IDYA - ETNB
55%
Loosely correlated
+1.99%
BEAM - ETNB
51%
Loosely correlated
+3.94%
IRON - ETNB
50%
Loosely correlated
+1.00%
CRNX - ETNB
50%
Loosely correlated
+5.17%
More